Ocata Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata”; NASDAQ: OCAT), a leader in the field of regenerative ophthalmology, today announced that Paul Wotton, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, 2015 at 2:00 p.m. EDT in New York City. A live audio webcast of the presentation will be available via the “Investor Relations” page of the Ocata website, www.ocata.com. A repla


R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent for Diabetic Retinopathy and Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) with Hokkaido University

TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with a group led by Professor Susumu Ishida and Associate Professor Kousuke Noda of the Department of Ophthalmology, Graduate Scho…